CASi-APOE

N/A

Report date: 2024/12/19 10:37:41
NME

Base Information

Drug NameCASi-APOE
Drug Alias NameCASi-APOE
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAnti-Apolipoprotein E
TargetsApolipoprotein E
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesSwitch Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSwitch Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A